Literature DB >> 14657578

Clinical trials with GDEPT: cytosine deaminase and 5-fluorocytosine.

Nicola L Brown1, Nicholas R Lemoine.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 14657578     DOI： 10.1385/1-59259-429-8:451

Source DB:  PubMed          Journal:  Methods Mol Med        ISSN： 1543-1894


× No keyword cloud information.
  4 in total

1.  Kinase domain insert containing receptor promotor controlled suicide gene system kills human umbilical vein endothelial cells.

Authors:  Zong-Hai Huang; Wen-Yu Yang; Qi Cheng; Jing-Long Yu; Zhou Li; Zong-Yan Tong; Hui-Juan Song; Xiao-Yan Che
Journal:  World J Gastroenterol       Date:  2005-06-28       Impact factor: 5.742

2.  Antitumor activity of mutant bacterial cytosine deaminase gene for colon cancer.

Authors:  Long-Ying Deng; Jian-Ping Wang; Zhi-Fu Gui; Li-Zong Shen
Journal:  World J Gastroenterol       Date:  2011-06-28       Impact factor: 5.742

3.  Kinase domain insert containing receptor promoter controlled suicide gene system selectively kills human umbilical vein endothelial cells.

Authors:  Wen-Yu Yang; Zong-Hai Huang; Li-Jun Lin; Zhou Li; Jing-Long Yu; Hui-Juan Song; Yong Qian; Xiao-Yan Che
Journal:  World J Gastroenterol       Date:  2006-09-07       Impact factor: 5.742

4.  Design, synthesis and biological evaluation of 2H-benzo[b][1,4] oxazine derivatives as hypoxia targeted compounds for cancer therapeutics.

Authors:  Bhaskar C Das; Ankanahlli V Madhukumar; Jaime Anguiano; Sridhar Mani
Journal:  Bioorg Med Chem Lett       Date:  2009-06-02       Impact factor: 2.823
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.